{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1070299362553883151.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@language":"en","@value":"Morohashi, Tamaki"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1050299362553883136","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"HDL","@value":"https://hdl.handle.net/20.500.14094/0100486381"},{"@type":"DOI","@value":"10.1007/s10157-023-02431-0"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s10157-023-02431-0.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s10157-023-02431-0/fulltext.html"},{"@type":"PMID","@value":"38010466"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2025142445"}],"notation":[{"@language":"en","@value":"Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01257:0006038891_GUsuuektusASKjItGzN6zhgUyXo"},{"@type":"CROSSREF","@value":"10.1007/s10157-023-02431-0_4To6khNwlGGGIgEdzbQ3rJlsBUy"},{"@type":"OPENAIRE","@value":"doi_dedup___::6d1196462e780ab869ae9de495a20434_4To6khNwlGGGIgEdzbQ3rJlsBUy"}]}